146 related articles for article (PubMed ID: 35058144)
1. Prognostic Value of Galectin Expression in Patients with Breast Cancer: Systematic Review and Meta-Analysis.
Ramos-Martínez JC; Altamirano-Gómez G; Ramos-Martínez I; Valencia J; Hernández-Zimbrón L; Hernández-Juárez J; Echeverría-Vásquez P; Hernández-González LL; Pérez-Campos E; Pérez-Campos Mayoral L; Ramos-Martínez E
Clin Breast Cancer; 2022 Jul; 22(5):399-409. PubMed ID: 35058144
[TBL] [Abstract][Full Text] [Related]
2. Association between high galectin expression and poor prognosis in hematologic cancers: a systematic review and meta-analysis.
Liu H; Dai Q; Li Y; Tang Z; She T
Hematology; 2023 Dec; 28(1):2227494. PubMed ID: 37343172
[TBL] [Abstract][Full Text] [Related]
3. Prognostic and diagnostic significance of galectins in pancreatic cancer: a systematic review and meta-analysis.
Sun Q; Zhang Y; Liu M; Ye Z; Yu X; Xu X; Qin Y
Cancer Cell Int; 2019; 19():309. PubMed ID: 31832021
[TBL] [Abstract][Full Text] [Related]
4. Clinical characteristics and prognostic significance of galectins for patients with gastric cancer: A meta-analysis.
Long B; Yu Z; Zhou H; Ma Z; Ren Y; Zhan H; Li L; Cao H; Jiao Z
Int J Surg; 2018 Aug; 56():242-249. PubMed ID: 29940258
[TBL] [Abstract][Full Text] [Related]
5. Prognostic role of galectins expression in patients with hepatic cancer: A meta-analysis.
Shao Q; He J; Chen Z; Wu C
Medicine (Baltimore); 2020 Apr; 99(15):e19622. PubMed ID: 32282710
[TBL] [Abstract][Full Text] [Related]
6. Association between Galectin Levels and Neurodegenerative Diseases: Systematic Review and Meta-Analysis.
Ramos-Martínez E; Ramos-Martínez I; Sánchez-Betancourt I; Ramos-Martínez JC; Peña-Corona SI; Valencia J; Saucedo R; Almeida-Aguirre EKP; Cerbón M
Biomolecules; 2022 Jul; 12(8):. PubMed ID: 36008956
[TBL] [Abstract][Full Text] [Related]
7. Galectin signatures contribute to the heterogeneity of breast cancer and provide new prognostic information and therapeutic targets.
Grosset AA; Labrie M; Vladoiu MC; Yousef EM; Gaboury L; St-Pierre Y
Oncotarget; 2016 Apr; 7(14):18183-203. PubMed ID: 26933916
[TBL] [Abstract][Full Text] [Related]
8. The Prognostic Value of Forkhead Box P3 Expression in Operable Breast Cancer: A Large-Scale Meta-Analysis.
Lin SC; Gan ZH; Yao Y; Min da L
PLoS One; 2015; 10(8):e0136374. PubMed ID: 26305693
[TBL] [Abstract][Full Text] [Related]
9. Varied expression and localization of multiple galectins in different cancer cell lines.
Satelli A; Rao PS; Gupta PK; Lockman PR; Srivenugopal KS; Rao US
Oncol Rep; 2008 Mar; 19(3):587-94. PubMed ID: 18288388
[TBL] [Abstract][Full Text] [Related]
10. Galectins-1, -3, and -7 Are Prognostic Markers for Survival of Ovarian Cancer Patients.
Schulz H; Schmoeckel E; Kuhn C; Hofmann S; Mayr D; Mahner S; Jeschke U
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28594391
[TBL] [Abstract][Full Text] [Related]
11. Galectins-1, -3, -7, -8 and -9 as prognostic markers for survival in epithelial ovarian cancer: A systematic review and meta-analysis.
Pergialiotis V; Papoutsi E; Androutsou A; Tzortzis AS; Frountzas M; Papapanagiotou A; Kontzoglou K
Int J Gynaecol Obstet; 2021 Mar; 152(3):299-307. PubMed ID: 33156523
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological and prognostic value of hypoxia-inducible factor-1α in breast cancer: a meta-analysis including 5177 patients.
Zhao Z; Mu H; Li Y; Liu Y; Zou J; Zhu Y
Clin Transl Oncol; 2020 Oct; 22(10):1892-1906. PubMed ID: 32166713
[TBL] [Abstract][Full Text] [Related]
13. Impact of estrogen receptor-β expression on breast cancer prognosis: a meta-analysis.
Liu J; Guo H; Mao K; Zhang K; Deng H; Liu Q
Breast Cancer Res Treat; 2016 Feb; 156(1):149-62. PubMed ID: 26902609
[TBL] [Abstract][Full Text] [Related]
14. Association of Cyclin-Dependent Kinases 4 and 6 Inhibitors With Survival in Patients With Hormone Receptor-Positive Metastatic Breast Cancer: A Systematic Review and Meta-analysis.
Li J; Huo X; Zhao F; Ren D; Ahmad R; Yuan X; Du F; Zhao J
JAMA Netw Open; 2020 Oct; 3(10):e2020312. PubMed ID: 33048129
[TBL] [Abstract][Full Text] [Related]
15. Predictive and prognostic role of tumour-infiltrating lymphocytes in breast cancer patients with different molecular subtypes: a meta-analysis.
Gao ZH; Li CX; Liu M; Jiang JY
BMC Cancer; 2020 Nov; 20(1):1150. PubMed ID: 33238978
[TBL] [Abstract][Full Text] [Related]
16. Galectins-1 and -3 and their ligands in tumor biology. Non-uniform properties in cell-surface presentation and modulation of adhesion to matrix glycoproteins for various tumor cell lines, in biodistribution of free and liposome-bound galectins and in their expression by breast and colorectal carcinomas with/without metastatic propensity.
André S; Kojima S; Yamazaki N; Fink C; Kaltner H; Kayser K; Gabius HJ
J Cancer Res Clin Oncol; 1999; 125(8-9):461-74. PubMed ID: 10480338
[TBL] [Abstract][Full Text] [Related]
17. Galectin-8 is associated with recurrence and survival of patients with non-metastatic gastric cancer after surgery.
Wu S; Liu H; Zhang H; Lin C; Li R; Cao Y; He H; Li H; Shen Z; Qin J; Xu J
Tumour Biol; 2016 Sep; 37(9):12635-12642. PubMed ID: 27444274
[TBL] [Abstract][Full Text] [Related]
18. The expression of Galectin-3 in breast cancer and its association with metastatic disease: a systematic review of the literature.
Boutas I; Potiris A; Makrakis E; Messaropoulos P; Papaioannou GK; Kalantaridou SΝ
Mol Biol Rep; 2021 Jan; 48(1):807-815. PubMed ID: 33398681
[TBL] [Abstract][Full Text] [Related]
19. Galectin-9, a novel prognostic factor with antimetastatic potential in breast cancer.
Yamauchi A; Kontani K; Kihara M; Nishi N; Yokomise H; Hirashima M
Breast J; 2006; 12(5 Suppl 2):S196-200. PubMed ID: 16959001
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological and prognostic significance of COX-2 immunohistochemical expression in breast cancer: a meta-analysis.
Xu F; Li M; Zhang C; Cui J; Liu J; Li J; Jiang H
Oncotarget; 2017 Jan; 8(4):6003-6012. PubMed ID: 27999206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
